Biopreservation Market Set For Strong Growth Through 2035 As Expanding Applications And Rising Cell Provider Volumes Unlock New Opportunities

(MENAFN- GlobeNewsWire - Nasdaq) Cell and gene therapies are driving demand for smart, resilient biopreservation, creating opportunities in specialized media, iPSC banking and room-temperature storage.

Dublin, Sept. 16, 2026 (GLOBE NEWSWIRE) -- "Biopreservation Market by Product; Application; Cell Providers Volume; Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035" has been added to ResearchAndMarkets.com's offering.

Global Biopreservation Market to Reach USD 44.45 Billion by 2035, Driven by Cell and Gene Therapy Expansion

The global biopreservation market is entering a period of significant growth as regenerative medicine, stem cell research, biobanking, and cell and gene therapies become increasingly important across the life sciences industry. Valued at USD 4.52 billion in 2025, the market is projected to reach USD 44.45 billion by 2035, expanding at a compound annual growth rate of 25.68% from 2026 to 2035.

Demand for advanced biopreservation systems is rising as more cell-based therapies progress from research and clinical development to commercial manufacturing. These therapies require reliable preservation of living biological materials throughout collection, processing, storage, transportation, and administration. As a result, biopreservation has become a critical component of biomedical research, biomanufacturing, clinical logistics, and long-term sample management.

Market Developments and Competitive Landscape

The biopreservation market remains moderately consolidated, particularly within the equipment and general consumables segments. Leading companies, including Thermo Fisher Scientific, Merck KGaA, and Avantor, have developed strong market positions by offering integrated solutions that combine storage equipment, preservation media, consumables, and digital tracking platforms. These end-to-end systems support workflow efficiency while simplifying procurement and sample management.

Product innovation is increasingly focused on automation, operational resilience, and sample security. Manufacturers are developing lower-viscosity cryopreservation media compatible with automated handling and robotic processing platforms. Advanced freezers are also incorporating backup cooling capabilities, including liquid nitrogen injection systems, to protect critical biological materials during power failures or equipment malfunctions. These technologies are accelerating the transition toward intelligent, connected, and fail-safe biopreservation infrastructure.

Primary Biopreservation Market Growth Drivers

Regenerative medicine and the commercialization of cell and gene therapies are among the strongest drivers of market expansion. Regulatory approvals for advanced treatments, including CAR-T therapies, have increased the need for validated preservation processes capable of maintaining cell quality, viability, and therapeutic performance.

Support from regulatory authorities such as the U.S. Food and Drug Administration and the European Medicines Agency is also contributing to market development. As the pipeline of advanced therapies expands, biopharmaceutical companies, healthcare providers, research institutions, and logistics specialists are expected to increase investment in cryopreservation equipment, storage media, monitoring software, and temperature-controlled transportation.

Emerging Opportunities and Market Challenges

Room-temperature preservation represents a major long-term opportunity for the global biopreservation market. Technologies based on desiccation and chemical stabilization could reduce reliance on ultra-low-temperature freezers and liquid nitrogen storage. Wider adoption may lower energy consumption, reduce infrastructure requirements, and simplify the transportation of biological samples across global biomedical supply chains.

However, the high cost of automation continues to limit adoption among smaller laboratories, academic institutions, and research centers. Automated preservation and sample-handling systems can improve consistency, throughput, and reproducibility, but they often require substantial upfront investment. Larger pharmaceutical and biotechnology companies are generally better positioned to implement sophisticated infrastructure, while budget-constrained organizations may remain dependent on manual workflows.

Market Segmentation Highlights

By product, the media segment is projected to register a CAGR of approximately 32% during the forecast period. This growth reflects increasing demand for specialized, recurring-use consumables across cell therapy manufacturing, biobanking, and research workflows. The broader product market includes equipment, consumables, media, and laboratory information management systems.

By cell provider volume, the induced pluripotent stem cell segment is expected to achieve strong growth due to expanding applications in regenerative medicine, disease modeling, drug development, and personalized therapies. Other major cell categories include CD19+, CD34+, mesenchymal stem cells, tumor cells, and human embryonic stem cells.

By application, biobanking holds a leading position in the global biopreservation market. Biobanks support biomedical research and therapeutic development by ensuring the integrity, availability, traceability, and timely distribution of critical biological materials. Additional applications include regenerative medicine and drug discovery.

Key Market Segments

• By Product: Equipment, consumables, media, and laboratory information management systems
• By Application: Regenerative medicine, biobanking, and drug discovery
• By Cell Provider Volume: CD19+, CD34+, iPSC, MSC, tumor cells, hESC, and others
• By Region: North America, Europe, Asia-Pacific, the Middle East and Africa, and South America

Regional Market Outlook

North America leads the global biopreservation market, accounting for more than 47% of total revenue. The region benefits from substantial research and development investment, a high concentration of pharmaceutical and biotechnology companies, advanced healthcare infrastructure, and an established regulatory ecosystem.

The United States remains a major center for cell therapy research and commercialization. Support from organizations such as the FDA and the National Institutes of Health continues to strengthen scientific innovation, clinical development, and regulatory compliance. These advantages are expected to sustain North America's market leadership while Europe and Asia-Pacific expand their biobanking, biomanufacturing, and advanced therapy capabilities.

Leading Biopreservation Market Participants

• Azenta US, Inc.
• BioLife Solutions
• LabVantage Solutions, Inc.
• Biomatrica, Inc.
• MVE Biological Solutions
• Thermo Fisher Scientific, Inc.
• Panasonic
• X-Therma Inc.
• PrincetonCryo
• Stirling Ultracold
• Taylor-Wharton

Continued advances in preservation media, automated handling, digital sample tracking, resilient cold storage, and room-temperature stabilization are expected to shape the next phase of market development. With cell and gene therapies moving rapidly toward broader clinical and commercial adoption, the global biopreservation market is positioned to become an increasingly essential part of the life sciences value chain through 2035.

Key Attributes:

Report Attribute	Details
No. of Pages	290
Forecast Period	2025 - 2035
Estimated Market Value (USD) in 2025	$4.52 Billion
Forecasted Market Value (USD) by 2035	$44.45 Billion
Compound Annual Growth Rate	25.6%
Regions Covered	Global

Key Topics Covered:
Chapter 1. Executive Summary: Global Biopreservation Market
Chapter 2. Research Methodology & Research Framework
2.1. Research Objective
2.2. Product Overview
2.3. Market Segmentation
2.4. Qualitative Research
2.4.1. Primary & Secondary Sources
2.5. Quantitative Research
2.5.1. Primary & Secondary Sources
2.6. Breakdown of Primary Research Respondents, By Region
2.7. Assumption for Study
2.8. Market Size Estimation
2.9. Data Triangulation
Chapter 3. Global Biopreservation Market Overview
3.1. Industry Value Chain Analysis
3.1.1. Raw Material Suppliers (Media, Reagents, Cryoprotectants)
3.1.2. Biopreservation Equipment Manufacturers[SP1.1]
3.1.3. Solution & Media Providers
3.1.4. Biobanks & Storage Facilities[SP2.1]
3.1.5. Research Institutes & CROs
3.1.6. Pharmaceutical & Biotechnology Companies
3.1.7. End Users (Hospitals, Diagnostic Labs)
3.2. Industry Outlook
3.2.1. Rising Demand for Regenerative Medicine
3.2.2. Growth in Biobanking Activities[SP3.1]
3.2.3. Increasing Organ Transplantation Procedures[SP4.1]
3.2.4. Expansion of Cell & Gene Therapy Research[SP5.1]
3.2.5. Rising Investments in Biotechnology Sector[SP6.1]
3.2.6. Growing Demand for Personalized Medicine[SP7.1]
3.2.7. Technological Advancements in Cryopreservatio[SP8.1]n
3.2.8. Increasing Government & Private Funding
3.3. PESTLE Analysis
3.4. Porter's Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitutes
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Dynamics and Trends
3.5.1. Growth Drivers
3.5.1.1. Rising Demand for Regenerative Medicine
3.5.2. Restraints
3.5.3. Opportunity
3.5.4. Key Trend
3.6. Market Growth and Outlook
3.6.1. Market Revenue & Volume Estimates and Forecast (US$ Mn), 2020 - 2035
3.6.2. Price Trend Analysis, by Feedstock
Chapter 4. Competition Dashboard
4.1. Market Concentration Rate
4.2. Company Market Share Analysis (Value %), 2025
4.3. Competitor Mapping & Benchmarking
4.4. Startup Ecosystem Analysis
4.5. M&A and Funding Landscape
Chapter 5. Global Biopreservation Market Analysis
5.1. Key Insights
5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
5.2.1. By Product
5.2.1.1. Equipment
5.2.1.1.1. Refrigerators
5.2.1.1.2. Freezers
5.2.1.1.3. Consumables
5.2.1.1.3.1. Straws
5.2.1.1.3.2. Vials
5.2.1.1.3.3. Microtiter Plates
5.2.1.1.4. Bags
5.2.1.1.5. Liquid Nitrogen
5.2.1.2. Media
5.2.1.2.1. Home-brew
5.2.1.2.2. Pre-formulated
5.2.1.3. Laboratory Information Management System (LIMS)
5.2.2. By Application
5.2.2.1. Regenerative Medicine
5.2.2.1.1. Gene Therapy
5.2.2.1.2. Cell Therapy
5.2.2.1.3. Others
5.2.2.2. Bio-banking
5.2.2.2.1. Human Sperms
5.2.2.2.2. Human Eggs
5.2.2.2.3. Veterinary IVF
5.2.2.3. Drug Discovery
5.2.3. By Cell Providers Volume
5.2.3.1. CD19+
5.2.3.2. CD34+
5.2.3.3. IPSC
5.2.3.4. MSC
5.2.3.5. Tumor Cells
5.2.3.6. HESC
5.2.3.7. Others
5.2.4. By Region
5.2.4.1. North America
5.2.4.1.1. The U.S.
5.2.4.1.2. Canada
5.2.4.1.3. Mexico
5.2.4.2. Europe
5.2.4.2.1. Western Europe
5.2.4.2.1.1. The UK
5.2.4.2.1.2. Germany
5.2.4.2.1.3. France
5.2.4.2.1.4. Italy
5.2.4.2.1.5. Spain
5.2.4.2.1.6. Rest of Western Europe
5.2.4.2.2. Eastern Europe
5.2.4.2.2.1. Poland
5.2.4.2.2.2. Russia
5.2.4.2.2.3. Rest of Eastern Europe
5.2.4.3. Asia-Pacific
5.2.4.3.1. China
5.2.4.3.2. India
5.2.4.3.3. Japan
5.2.4.3.4. South Korea
5.2.4.3.5. Australia & New Zealand
5.2.4.3.6. ASEAN
5.2.4.3.6.1. Indonesia
5.2.4.3.6.2. Malaysia
5.2.4.3.6.3. Thailand
5.2.4.3.6.4. Singapore
5.2.4.3.6.5. Rest of ASEAN
5.2.4.3.7. Rest of Asia-Pacific
5.2.4.4. Middle East & Africa
5.2.4.4.1. UAE
5.2.4.4.2. Saudi Arabia
5.2.4.4.3. South Africa
5.2.4.4.4. Rest of MEA
5.2.4.5. South America
5.2.4.5.1. Argentina
5.2.4.5.2. Brazil
5.2.4.5.3. Rest of South America
Chapter 6. North America Biopreservation Market Analysis
6.1. Market Dynamics and Trends
6.1.1. Growth Drivers
6.1.2. Restraints
6.1.3. Opportunity
6.1.4. Key Trends
6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
6.2.1. By Product Type
6.2.2. By Application
6.2.3. By Cell Providers Volume
6.2.4. By Country
Chapter 7. Europe Biopreservation Market Analysis
7.1. Market Dynamics and Trends
7.1.1. Growth Drivers
7.1.2. Restraints
7.1.3. Opportunity
7.1.4. Key Trends
7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By Cell Providers Volume
7.2.4. By Country
Chapter 8. Asia-Pacific Biopreservation Market Analysis
8.1. Market Dynamics and Trends
8.1.1. Growth Drivers
8.1.2. Restraints
8.1.3. Opportunity
8.1.4. Key Trends
8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By Cell Providers Volume
8.2.4. By Country
Chapter 9. Middle East & Africa Biopreservation Market Analysis
9.1. Market Dynamics and Trends
9.1.1. Growth Drivers
9.1.2. Restraints
9.1.3. Opportunity
9.1.4. Key Trends
9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
9.2.1. By Product Type
9.2.2. By Application
9.2.3. By Cell Providers Volume
9.2.4. By Country
Chapter 10. South America Biopreservation Market Analysis
10.1. Market Dynamics and Trends
10.1.1. Growth Drivers
10.1.2. Restraints
10.1.3. Opportunity
10.1.4. Key Trends
10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
10.2.1. By Product Type
10.2.2. By Application
10.2.3. By Cell Providers Volume
10.2.4. By Country
Chapter 11. Company Profiles ([SP9.1]Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
11.1. Azenta US, Inc.
11.2. BioLife Solutions
11.3. LabVantage Solutions, Inc.
11.4. Biomatrica, Inc.
11.5. MVE Biological Solutions
11.6. Thermo Fisher Scientific, Inc.
11.7. Panasonic
11.8. X-Therma Inc.
11.9. PrincetonCryo
11.10. Stirling Ultracold
11.11. Taylor-Wharton
11.12. Other Prominent Players
Chapter 12. Annexure
12.1. List of Secondary Sources
12.2. Macro-Economic Outlook/Indicators
A selection of companies mentioned in this report includes, but is not limited to:

• Azenta US, Inc.
• BioLife Solutions
• LabVantage Solutions, Inc.
• Biomatrica, Inc.
• MVE Biological Solutions
• Thermo Fisher Scientific, Inc.
• Panasonic
• X-Therma Inc.
• PrincetonCryo
• Stirling Ultracold
• Taylor-Wharton

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN16092026004107003653ID1111672410